Objective: To investigate whether intravitreal corticosteroid therapy reduc
es the extent of inflammatory intraocular tissue damage caused by Bacillus
cereus endophthalmitis.
Methods: New Zealand white rabbits were inoculated with 1 X 10(6) B cereus
organisms and randomized to receive no treatment (control eyes; n=14), intr
avitreal vancomycin hydrochloride (n=13), or a combination of intravitreal
vancomycin and dexamethasone sodium phosphate (n=13) after 24 hours. The ey
es were examined and graded for clinical signs of infection and inflammatio
n on days 7 and 14, followed by enucleation for histopathologic analysis.
Results: Both treated groups had significantly less clinical sequelae than
controls on day 7. By day 14, eyes given combination treatment had signific
antly less clinically graded corneal (P=.03) and conjunctival (P=.007) infl
ammation than eyes treated with vancomycin. Histopathologic analysis reveal
ed a significant decrease in inflammatory changes between all treated eyes
and controls at day 14. The only statistically significant difference betwe
en eyes given combination treatment and eyes given vancomycin alone was in
the retina (P=.03).
Conclusions: Intravitreal corticosteroids may enhance the recovery from B c
ereus endophthalmitis when given in conjunction with intravitreal antibioti
cs. The beneficial effect of corticosteroids is noted clinically, but not h
istologically, by day 14 after single-dose treatment in rabbits.
Clinical Relevance: This study provides evidence that the use of intravitre
al corticosteroids with antibiotics for the treatment of B cereus endophtha
lmitis may lead to an improvement compared with the use of antibiotics alon
e.